Mycobacterium avium and modulation of the host macrophage immune mechanisms

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 4, 2011, Pages 447-452

  Rocco, J M ^a   Irani, Vida R ^a  

^a INDIANA UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Glycopeptidolipids; Mitogen activated protein kinase; Mycobacterium avium; Toll like receptor 2; Tumor necrosis factor alpha

Indexed keywords

GAMMA INTERFERON; GLYCOPEPTIDOLIPID; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; RANTES; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BACTERIAL VIRULENCE; CARBOHYDRATE ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GLYCOLIPIDS; GLYCOPEPTIDES; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

EID: 79952792510     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.09.0695     Document Type: Review

References (34)

1. Chatterjee D, Khoo K-H. The surface glycopeptidolipids of mycobacteria: structures and biological properties. Cell Mol Life Sci 2001; 58: 2018-2042. (Pubitemid 34019216)
2. Parrish S C, Myers J, Lazarus A. Nontuberculous mycobacterial pulmonary infections in non-HIV patients. Postgrad Med 2008; 120: 78-86.
3. von Reyn C F, Jacobs N J, Arbeit R D, Maslow J N, Neimczyk S. Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J Clin Microbiol 1995; 33: 1008-1010.
4. Dailloux M, Abalain M, Laurain C, et al.; French Mycobacteria Study Group. Respiratory infections associated with non-tuberculous mycobacteria in non-HIV patients. Eur Respir J 2006; 28: 1211-1215.
5. Pathak S K, Bhattacharyya A, Pathak S. Toll-like receptor 2 and mitogen- and stress-activated kinase 1 are effectors of Mycobacterium avium-induced cyclooxygenase-2 expression in macrophages. J Biol Chem 2004; 279: 55127-55136.
6. Biet F, Bay S, Thibault V C. Lipopentapeptide induces a strong host humoral response and distinguishes Mycobacterium avium subsp. paratuberculosis from M. avium subsp. avium. Vaccine 2008; 26: 257-268. (Pubitemid 50009653)
7. Bhatnagar S, Schorey J S. Elevated mitogen-activated protein kinase signaling and increased macrophage activation in cells infected with a glycopeptidolipid-deficient Mycobacterium avium. Cell Microbiol 2006; 8: 85-96. (Pubitemid 43355523)
8. Schorey J S, Sweet L. The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis. Glycobiology 2008; 18: 832-841.
9. Irani V R, Maslow J N. Induction of murine macrophage TNF-α synthesis by Mycobacterium avium is modulated through complement-dependent interaction via complement receptors 3 and 4 in relation to M. avium glycopeptidolipid. FEMS M icrobiol Lett 2005; 246: 221-228. (Pubitemid 40724433)
10. Bermudez L. Immunobiology of Mycobacterium avium infection. Eur J Clin Microbiol Infect Dis 1994; 13: 1000-1006.
11. Sweet L, Schorey J S. Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88 dependent manner. J Leukoc Biol 2006; 80: 415-423.
12. Sweet L, Wenhui Z, Torres-Fewell H, Serianni A, Boggess W, Schorey J S. Mycobacterium avium glycopeptidolipids require specific acetylation and methylation patterns for signalling through toll-like receptor 2. J Biol Chem 2008; 283: 33221-33231.
13. Sampaio E P, Elloumi H Z, Zelazny A. Mycobacterium abscessus and M. avium trigger toll-like receptor 2 and distinct cytokine response in human cells. Am J Respir Cell Mol Biol 2008; 39: 431-439.
14. Bhattacharyya A, Pathak S, Basak C, Law S, Kundu M, Basu J. Execution of macrophage apoptosis by Mycobacterium avium through apoptosis signal-regulating kinase 1/p38 mitogen-activated protein kinase signaling and caspase 8 activation. J Biol Chem 2003; 278: 26517-26525.
15. Gutierrez M G, Mishra B B, Jordao L, Elliott E, Anes E, Griffiths G. NF-κB activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages. J Immunol 2008; 181: 2651-2663.
16. Yamamoto M, Takeda K. Role of nuclear IêB proteins in the regulation of host immune responses. J Infect Chemother 2008; 14: 265-269.
17. Gutierrez M G, Gonzalez A P, Anes E, Griffiths G. Role of lipids in killing mycobacteria by macrophages: evidence for NF-κB dependent and independent killing induced by different lipids. Cell Microbiol 2009; 11: 406-420.
18. Chastellier C, Forquet F, Gordon A, Thilo L. Mycobacterium requires an all-around closely apposing phagosome membrane to maintain the maturation block and this apposition is reestablished when it rescues itself from phagolysosomes. Cell Microbiol 2009; 11: 1190-1207.
19. Danelishvilli L, Bermudez L E. Role of type I cytokines in host defense against Mycobacterium avium infection. Curr Pharm Des 2003; 9: 61-65.
20. Bermudez L E, Parker A, Petrofsky M. Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumor necrosis factor (TNF) and Fas, and involves the activation of caspases. Clin Exp Immunol 1999; 116: 94-99.
21. Gomes S M, Appelberg R. NRAMP1- or cytokine-induced bacteriostasis of Mycobacterium avium by mouse macrophages is independent of the respiratory burst. Microbiol 2002; 148: 3155-3160.
22. Roach S K, Schorey J S. Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect Immun 2002; 70: 3040-3052. (Pubitemid 34564165)
23. Bhatnagar S, Schorey J S. Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J Biol Chem 2007; 282: 25779-25789.
24. Florido M, Goncalves A S, Gomes M S, Appelberg R. CD40 is required for the optimal induction of protective immunity to Mycobacterium avium. Immunol 2004; 111: 323-327. (Pubitemid 38365755)
25. Bermudez L, Wu M, Young L S. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect Immun 1995; 63: 4099-4104.
26. Wagner D, Sangari F J, Kim S, Petrofsky M, Bermudez L. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo. J Leukoc Biol 2002; 71: 80-88.
27. McGarvey J, Bermudez L. Pathogenesis of nontuberculous mycobacteria infections. Clin Chest Med 2002; 23: 1-15.
28. Gomes M S, Florido M, Pais T F, Appelberg R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J Immunol 1999; 162: 6734-6739.
29. Vazquez N, Greenwell-Wild T, Rekka S, Orenstein J, Wahl S M. Mycobacterium avium-induced SOCS contributes to resistance to IFN-γ-mediated mycobactericidal activity in human macrophages. J Leuk Biol 2006; 80: 1136-1144.
30. Sheedy F J, McDermott E P, Hennessy E J, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11: 141-147.
31. Krzywinska E, Bhatnagar S, Sweet L, Chatterjee D, Schorey J S. Mycobacterium avium 104 deleted of the methyltransferase D gene by allelic replacement lacks serotype-specific glycopeptidolipids and shows attenuated virulence in mice. Mol Microbiol 2005; 56: 1262-1273.
32. Kano H, Doi T, Fujita Y, Takimoto H, Yano I, Kumazawa Y. Serotype-specific modulation of human monocyte functions by glycopeptidolipid (GPL) isolated from Mycobacterium avium complex. Biol Pharm Bull 2005; 28: 335-339. (Pubitemid 40880019)
33. Barrow W W, Carvalho de Sousa J P, Davis T L, Wright E L, Bachelet M, Rastogi N. Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium. Infect Immun 1993; 61: 5286-5293. (Pubitemid 23353910)
34. Barrow W W, Davis T L, Wright E L, Labrousse V, Bachelet M, Rastogi N. Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect Immun 1995; 63: 126-133.